S100A16 and glioblastoma: For the GEPIA-derived cohort, the expression levels of S100A11, S100A16, and S100B in low-grade glioma (LGG) and GBM samples increased compared with those in noncarcinoma samples, while S10013 in LGG tissue was upregulated in normal tissues (Figure 8).